{"title":"加速不育检测:Symcel calScreener+在无损连续监测系统中直接接种,可在<3天内取得结果","authors":"W. Paulander","doi":"10.1016/j.jcyt.2025.03.034","DOIUrl":null,"url":null,"abstract":"<div><h3>Background & Aim</h3><div>Sterility testing is a critical quality control process for cell and gene therapy products (CGTPs), where rapid and reliable detection of microbial contaminants is essential to meet regulatory standards and ensure patient safety. Traditional sterility testing methods, requiring up to 14 days, delay batch release and increase costs. The Symcel calScreener+ utilizes isothermal microcalorimetry to enable faster, phenotypic detection of microbial contaminants in a non-destructive and product-matrix-independent manner. This study evaluates the calScreener+ 3-day sterility test for its accuracy, reliability, detection times, and robustness in addressing challenges such as small sample volumes and complex matrices with high eukaryotic cell concentrations.</div></div><div><h3>Methodology</h3><div>The calScreener+ monitors metabolic activity in product samples as low as 0.05 ml to detect microbial growth. Validation studies assessed its Limit of Detection (LOD), detection times, comparability, and specificity range across 20 microbial strains relevant to regulatory guidelines. The evaluation used TSB and FTM media at dual temperatures (25°C and 35°C) and included key microorganisms such as <em>Staphylococcus aureus, Pseudomonas aeruginosa, Candida albicans, Aspergillus brasiliensis</em>, and <em>Cutibacterium acnes</em>. Robustness and ruggedness were assessed under varying conditions, including temperature fluctuations and growth inhibitors. Statistical analyses confirmed reliability and reproducibility.</div></div><div><h3>Results</h3><div>The calScreener+ demonstrated an LOD of <5 CFU and delivered results within 3 days, even in complex matrices with high eukaryotic cell concentrations (10^6–10^8 cells/ml). Detection times included <em>S. aureus, P. aeruginosa</em>, and <em>C. albicans</em> within 24 hours; <em>A. brasiliensis</em> within 30 hours; and <em>C. acnes</em> within 60 hours. It effectively detected a broad range of microorganisms relevant to sterility testing, including critical contaminants such as <em>Burkholderia</em> complex and <em>Penicillium</em> species, with robust performance under varying conditions.</div></div><div><h3>Conclusion</h3><div>The Symcel calScreener+ offers a sensitive and rapid solution for sterility testing in CGTPs, enabling phenotypic detection of microbial contaminants within days instead of weeks. Its small sample volume minimizes material use, ideal for limited batch sizes. By eliminating enrichment steps and reducing detection times, the calScreener+ streamlines workflows and enhances operational efficiency, positioning it as a transformative tool for pharmaceutical quality control.</div></div>","PeriodicalId":50597,"journal":{"name":"Cytotherapy","volume":"27 5","pages":"Page S24"},"PeriodicalIF":3.7000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Accelerating sterility testing: Symcel calScreener+ achieves results in <3 days with direct inoculation in non-destructive and continuous monitoring system\",\"authors\":\"W. Paulander\",\"doi\":\"10.1016/j.jcyt.2025.03.034\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background & Aim</h3><div>Sterility testing is a critical quality control process for cell and gene therapy products (CGTPs), where rapid and reliable detection of microbial contaminants is essential to meet regulatory standards and ensure patient safety. Traditional sterility testing methods, requiring up to 14 days, delay batch release and increase costs. The Symcel calScreener+ utilizes isothermal microcalorimetry to enable faster, phenotypic detection of microbial contaminants in a non-destructive and product-matrix-independent manner. This study evaluates the calScreener+ 3-day sterility test for its accuracy, reliability, detection times, and robustness in addressing challenges such as small sample volumes and complex matrices with high eukaryotic cell concentrations.</div></div><div><h3>Methodology</h3><div>The calScreener+ monitors metabolic activity in product samples as low as 0.05 ml to detect microbial growth. Validation studies assessed its Limit of Detection (LOD), detection times, comparability, and specificity range across 20 microbial strains relevant to regulatory guidelines. The evaluation used TSB and FTM media at dual temperatures (25°C and 35°C) and included key microorganisms such as <em>Staphylococcus aureus, Pseudomonas aeruginosa, Candida albicans, Aspergillus brasiliensis</em>, and <em>Cutibacterium acnes</em>. Robustness and ruggedness were assessed under varying conditions, including temperature fluctuations and growth inhibitors. Statistical analyses confirmed reliability and reproducibility.</div></div><div><h3>Results</h3><div>The calScreener+ demonstrated an LOD of <5 CFU and delivered results within 3 days, even in complex matrices with high eukaryotic cell concentrations (10^6–10^8 cells/ml). Detection times included <em>S. aureus, P. aeruginosa</em>, and <em>C. albicans</em> within 24 hours; <em>A. brasiliensis</em> within 30 hours; and <em>C. acnes</em> within 60 hours. It effectively detected a broad range of microorganisms relevant to sterility testing, including critical contaminants such as <em>Burkholderia</em> complex and <em>Penicillium</em> species, with robust performance under varying conditions.</div></div><div><h3>Conclusion</h3><div>The Symcel calScreener+ offers a sensitive and rapid solution for sterility testing in CGTPs, enabling phenotypic detection of microbial contaminants within days instead of weeks. Its small sample volume minimizes material use, ideal for limited batch sizes. By eliminating enrichment steps and reducing detection times, the calScreener+ streamlines workflows and enhances operational efficiency, positioning it as a transformative tool for pharmaceutical quality control.</div></div>\",\"PeriodicalId\":50597,\"journal\":{\"name\":\"Cytotherapy\",\"volume\":\"27 5\",\"pages\":\"Page S24\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cytotherapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1465324925001203\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cytotherapy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1465324925001203","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
Accelerating sterility testing: Symcel calScreener+ achieves results in <3 days with direct inoculation in non-destructive and continuous monitoring system
Background & Aim
Sterility testing is a critical quality control process for cell and gene therapy products (CGTPs), where rapid and reliable detection of microbial contaminants is essential to meet regulatory standards and ensure patient safety. Traditional sterility testing methods, requiring up to 14 days, delay batch release and increase costs. The Symcel calScreener+ utilizes isothermal microcalorimetry to enable faster, phenotypic detection of microbial contaminants in a non-destructive and product-matrix-independent manner. This study evaluates the calScreener+ 3-day sterility test for its accuracy, reliability, detection times, and robustness in addressing challenges such as small sample volumes and complex matrices with high eukaryotic cell concentrations.
Methodology
The calScreener+ monitors metabolic activity in product samples as low as 0.05 ml to detect microbial growth. Validation studies assessed its Limit of Detection (LOD), detection times, comparability, and specificity range across 20 microbial strains relevant to regulatory guidelines. The evaluation used TSB and FTM media at dual temperatures (25°C and 35°C) and included key microorganisms such as Staphylococcus aureus, Pseudomonas aeruginosa, Candida albicans, Aspergillus brasiliensis, and Cutibacterium acnes. Robustness and ruggedness were assessed under varying conditions, including temperature fluctuations and growth inhibitors. Statistical analyses confirmed reliability and reproducibility.
Results
The calScreener+ demonstrated an LOD of <5 CFU and delivered results within 3 days, even in complex matrices with high eukaryotic cell concentrations (10^6–10^8 cells/ml). Detection times included S. aureus, P. aeruginosa, and C. albicans within 24 hours; A. brasiliensis within 30 hours; and C. acnes within 60 hours. It effectively detected a broad range of microorganisms relevant to sterility testing, including critical contaminants such as Burkholderia complex and Penicillium species, with robust performance under varying conditions.
Conclusion
The Symcel calScreener+ offers a sensitive and rapid solution for sterility testing in CGTPs, enabling phenotypic detection of microbial contaminants within days instead of weeks. Its small sample volume minimizes material use, ideal for limited batch sizes. By eliminating enrichment steps and reducing detection times, the calScreener+ streamlines workflows and enhances operational efficiency, positioning it as a transformative tool for pharmaceutical quality control.
期刊介绍:
The journal brings readers the latest developments in the fast moving field of cellular therapy in man. This includes cell therapy for cancer, immune disorders, inherited diseases, tissue repair and regenerative medicine. The journal covers the science, translational development and treatment with variety of cell types including hematopoietic stem cells, immune cells (dendritic cells, NK, cells, T cells, antigen presenting cells) mesenchymal stromal cells, adipose cells, nerve, muscle, vascular and endothelial cells, and induced pluripotential stem cells. We also welcome manuscripts on subcellular derivatives such as exosomes. A specific focus is on translational research that brings cell therapy to the clinic. Cytotherapy publishes original papers, reviews, position papers editorials, commentaries and letters to the editor. We welcome "Protocols in Cytotherapy" bringing standard operating procedure for production specific cell types for clinical use within the reach of the readership.